Effect of Trimethine Cyanine Dye- and Folate-Conjugation on the In Vitro Biological Activity of Proapoptotic Peptides.

cancer cyanine dyes folate mitochondria proapoptotic peptides solid-phase synthesis

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
20 05 2022
Historique:
received: 07 04 2022
revised: 10 05 2022
accepted: 16 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Despite continuous advances, anticancer therapy still faces several technical hurdles, such as selectivity on cellular and subcellular targets of therapeutics. Toward addressing these limitations, we have combined the use of proapoptotic peptides, trimethine cyanine dye, and folate to target the mitochondria of tumor cells. A series of proapoptotic peptides and their conjugates with a cyanine dye and/or folate were synthesized in the solid phase, and their toxicity in different human cell lines was assessed. Cyanine-bearing conjugates were found to be up to 100-fold more cytotoxic than the parent peptides and to localize in mitochondria. However, the addition of a folate motif did not enhance the potency or selectivity of the resulting conjugates toward tumor cells that overexpress folate receptor α. Furthermore, while dual-labeled constructs were also found to localize within the target organelle, they were not generally selective towards folate receptor α-positive cell lines in vitro.

Identifiants

pubmed: 35625652
pii: biom12050725
doi: 10.3390/biom12050725
pmc: PMC9138991
pii:
doi:

Substances chimiques

Folate Receptor 1 0
Peptides 0
Quinolines 0
Folic Acid 935E97BOY8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Bioconjug Chem. 2012 Jul 18;23(7):1357-69
pubmed: 22667324
J Biol Chem. 1993 Nov 25;268(33):24847-54
pubmed: 8227046
Bioconjug Chem. 2020 Feb 19;31(2):248-259
pubmed: 31909595
Cancer Med. 2014 Aug;3(4):775-86
pubmed: 24737784
Chem Commun (Camb). 2020 Apr 30;56(34):4672-4675
pubmed: 32211623
Bioconjug Chem. 2017 Jun 21;28(6):1709-1721
pubmed: 28485595
Clin Cancer Res. 2010 May 15;16(10):2833-44
pubmed: 20410058
J Med Chem. 2009 May 28;52(10):3293-9
pubmed: 19397319
Cancer Res. 2017 Jun 1;77(11):2784-2788
pubmed: 28455420
Chem Biol. 2008 Apr;15(4):375-82
pubmed: 18420144
Trends Mol Med. 2020 Jan;26(1):119-134
pubmed: 31327706
Biomaterials. 2011 Aug;32(22):5262-8
pubmed: 21565400
J Biol Chem. 1989 Sep 5;264(25):14893-901
pubmed: 2768245
Oncotarget. 2016 Aug 9;7(32):52553-52574
pubmed: 27248175
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5572-6
pubmed: 2062838
Mol Cancer Ther. 2006 Aug;5(8):1944-9
pubmed: 16928814
Sci Rep. 2018 May 30;8(1):8426
pubmed: 29849110
J Control Release. 1998 Apr 30;53(1-3):39-48
pubmed: 9741912
Bioinorg Chem Appl. 2021 Oct 13;2021:4763944
pubmed: 34691164
J Control Release. 2016 Aug 10;235:259-267
pubmed: 27282414
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27
pubmed: 26667886
J Drug Target. 1999;7(3):157-69
pubmed: 10680972
Chembiochem. 2012 Feb 13;13(3):476-85
pubmed: 22238158
Br J Cancer. 2015 Mar 3;112(5):943-7
pubmed: 25647015
J Am Chem Soc. 2016 Sep 28;138(38):12368-74
pubmed: 27574920
Mol Pharm. 2007 Sep-Oct;4(5):659-67
pubmed: 17874843
Sci Rep. 2013 Dec 16;3:3468
pubmed: 24336626
Bioorg Med Chem. 2015 May 1;23(9):2187-94
pubmed: 25819334
Cancer Res. 2001 Nov 1;61(21):7709-12
pubmed: 11691780
Ecancermedicalscience. 2019;13:961
pubmed: 31537986
Adv Drug Deliv Rev. 2000 Mar 30;41(2):147-62
pubmed: 10699311
Acta Biochim Pol. 2006;53(4):801-5
pubmed: 17143339
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Nat Med. 1999 Sep;5(9):1032-8
pubmed: 10470080
Bioconjug Chem. 2014 Mar 19;25(3):560-8
pubmed: 24564229
Chem Sci. 2017 Dec 18;9(4):790-810
pubmed: 29675145
Int J Mol Sci. 2019 Apr 30;20(9):
pubmed: 31052315
Ann Nucl Med. 2016 Jun;30(5):369-79
pubmed: 26993818
J Med Chem. 2019 Oct 24;62(20):9236-9245
pubmed: 31469566
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Int J Pharm. 2004 Dec 9;287(1-2):155-62
pubmed: 15541922
Science. 2001 Jul 6;293(5527):58-9
pubmed: 11441170
J Med Chem. 2021 Mar 25;64(6):3204-3221
pubmed: 33710891

Auteurs

Davide Cardella (D)

School of Chemistry, Main Building, Cardiff University, Park Place, Cardiff CF10 3AT, UK.

Wenjing Deng (W)

Shenzhen Bay Laboratory, Gaoke Innovation Center, Institute of Molecular Physiology, Guangming District, Shenzhen 518132, China.

Louis Y P Luk (LYP)

School of Chemistry, Main Building, Cardiff University, Park Place, Cardiff CF10 3AT, UK.

Yu-Hsuan Tsai (YH)

School of Chemistry, Main Building, Cardiff University, Park Place, Cardiff CF10 3AT, UK.
Shenzhen Bay Laboratory, Gaoke Innovation Center, Institute of Molecular Physiology, Guangming District, Shenzhen 518132, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH